ACCENTMIC Accent Microcell Q4 FY25 results (Jan–Mar 2025) and concall
Accent Microcell reported a strong FY25 with an 8% YoY increase in revenue to ₹265 crores and a 10% YoY increase in PAT to ₹33 crores. The company is progressing with its Unit 3 expansion, with Phase 1 expected to commence commercial production in September-October 2025, targeting ₹70 crores in H2 FY25 revenue from confirmed orders. Management highlighted improved margins from premium products and an increasing export ratio, while addressing concerns regarding working capital and a contingent NGT liability.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
| Line item | Q2 FY24 | Q4 FY24 | Q2 FY25 | Q4 FY25 |
|---|---|---|---|---|
| Revenue | 107 | 139 | 126 | 139 |
| EBITDA | 20 | 20 | 19 | 23 |
| Net profit | 14 | 16 | 16 | 17 |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
